Trial Profile
A study to examine low disease activity among patients receiving infliximab:US Corrona Ra Registry
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Aug 2016
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 12 Aug 2016 New trial record